Yujing Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yujing Huang has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Junxia Zheng
School of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou China
8 shared publications Duntao Zu
School of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou P.R. China
5 shared publicationsJianni Yang
College of Pharmacy Jinan University Guangzhou P.R. China
5 shared publicationsChengyin Huang
School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, 510006, PR China
3 shared publicationsChenjing Tian
School of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou P.R. China
3 shared publicationsJuntao Xie
School of Biomedical and Pharmaceutical Sciences Guangdong University of Technology Guangzhou P. R. China
3 shared publications
Latest Publications
- Open Access
- 27 September 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (9)
Magnetic Bead‐Based Ligand Fishing Identifies SARS‐CoV‐2 Main Protease Inhibitors From Reynoutria japonica
Traditional Chinese medicines (TCMs) are rich sources of structurally diverse bioactive compounds, yet rapid identification of protease inhibitors from complex botanical matrices remains challenging. Here, a magnetic bead‐based affinity‐fishing platform coupled with UPLC‐Q‐Exactive‐Orbitrap‐MS/MS was applied to identify SARS‐CoV‐2 main protease (M pro ) inhibitors from Reynoutria japonica . The crude ethanolic extract inhibited M pro with an IC 50 of 44.92 ± 2.31 µg/mL. M pro ‐functionalized magnetic beads enriched eight constituents, which were identified by high‐resolution mass spectrometry and evaluated using a FRET‐based inhibition assay. Six compounds showed concentration‐dependent activity, with resveratrol being the most potent (IC 50 = 34.01 ± 1.67 µmol/L), followed by glycitein, genistein, emodin, apigenin‐7‐ O ‐glucoside, and biochanin A. HPLC‐DAD further quantified the principal active constituents. Molecular docking suggested interactions with residues in the Mpro substrate‐binding pocket, while network pharmacology predicted associations with host‐related targets involving IL6, TNF, and AKT1. Overall, this workflow enables efficient enrichment, structural identification, and functional prioritization of M pro ‐inhibitory constituents from complex botanical extracts, providing a practical strategy for target‐directed natural product discovery.
- 27 September 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (9)
Open AccessMagnetic Bead‐Based Ligand Fishing Identifies SARS‐CoV‐2 Main Protease Inhibitors From Reynoutria japonica
Traditional Chinese medicines (TCMs) are rich sources of structurally diverse bioactive compounds, yet rapid identification of protease inhibitors from complex botanical matrices remains challenging. Here, a magnetic bead‐based affinity‐fishing platform coupled with UPLC‐Q‐Exactive‐Orbitrap‐MS/MS was applied to identify SARS‐CoV‐2 main protease (M pro ) inhibitors from Reynoutria japonica . The crude ethanolic extract inhibited M pro with an IC 50 of 44.92 ± 2.31 µg/mL. M pro ‐functionalized magnetic beads enriched eight constituents, which were identified by high‐resolution mass spectrometry and evaluated using a FRET‐based inhibition assay. Six compounds showed concentration‐dependent activity, with resveratrol being the most potent (IC 50 = 34.01 ± 1.67 µmol/L), followed by glycitein, genistein, emodin, apigenin‐7‐ O ‐glucoside, and biochanin A. HPLC‐DAD further quantified the principal active constituents. Molecular docking suggested interactions with residues in the Mpro substrate‐binding pocket, while network pharmacology predicted associations with host‐related targets involving IL6, TNF, and AKT1. Overall, this workflow enables efficient enrichment, structural identification, and functional prioritization of M pro ‐inhibitory constituents from complex botanical extracts, providing a practical strategy for target‐directed natural product discovery.
- Open Access
- 23 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8465
Structure-Guided Covalent Design and Biological Evaluation of Glycidamido-Leucinamide Antivirulence Agents Against Pseudomonas aeruginosa
Antimicrobial resistance in Pseudomonas aeruginosa has intensified the need for therapies that do not rely solely on bactericidal activity. Antivirulence agents attenuate pathogenic functions and may complement conventional antibiotics. The elastase LasB is a major quorum-sensing (QS)-controlled virulence factor of P. aeruginosa. Starting from the validated N-aryl/α-isobutyl recognition motif of LasB inhibitors, we used an integrated computational workflow combining chemical-space mapping of known LasB inhibitors, focused covalent-library enumeration, and Glu141-directed covalent docking to design glycidamide analogues bearing an epoxide-containing motif. Two compounds were synthesised and characterised, QSI-1 (4-(trifluoromethyl)phenyl) and QSI-2 (4-fluorophenyl), forming a matched molecular pair that differs only at the para substituent. Both compounds inhibited biofilm formation at sub-micromolar concentrations (QSI-1, IC50 = 0.28 μM; QSI-2, IC50 = 0.51 μM) and directly inhibited purified recombinant LasB, with IC50 values of 2.98 μM and 10.20 μM, respectively. Both also preferentially reduced lasB promoter activity relative to the rhlA and pqsA reporters. QSI-1, selected for further evaluation, reduced virulence-factor production and surface-associated motility without measurably inhibiting bacterial growth. QSI-1 enhanced the activity of azithromycin in vitro, and the combination of QSI-1 (25 μM) with azithromycin (0.05 μg/mL) accelerated wound closure and reduced bacterial burden in a murine excisional wound-infection model. QSI-1 showed low cytotoxicity toward mammalian cells at concentrations up to 200 μM. These findings identify QSI-1 and QSI-2 as covalently designed LasB-active antivirulence leads, while direct experimental confirmation of Glu141 covalent modification remains to be established.
- 23 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8465
Open AccessStructure-Guided Covalent Design and Biological Evaluation of Glycidamido-Leucinamide Antivirulence Agents Against Pseudomonas aeruginosa
Antimicrobial resistance in Pseudomonas aeruginosa has intensified the need for therapies that do not rely solely on bactericidal activity. Antivirulence agents attenuate pathogenic functions and may complement conventional antibiotics. The elastase LasB is a major quorum-sensing (QS)-controlled virulence factor of P. aeruginosa. Starting from the validated N-aryl/α-isobutyl recognition motif of LasB inhibitors, we used an integrated computational workflow combining chemical-space mapping of known LasB inhibitors, focused covalent-library enumeration, and Glu141-directed covalent docking to design glycidamide analogues bearing an epoxide-containing motif. Two compounds were synthesised and characterised, QSI-1 (4-(trifluoromethyl)phenyl) and QSI-2 (4-fluorophenyl), forming a matched molecular pair that differs only at the para substituent. Both compounds inhibited biofilm formation at sub-micromolar concentrations (QSI-1, IC50 = 0.28 μM; QSI-2, IC50 = 0.51 μM) and directly inhibited purified recombinant LasB, with IC50 values of 2.98 μM and 10.20 μM, respectively. Both also preferentially reduced lasB promoter activity relative to the rhlA and pqsA reporters. QSI-1, selected for further evaluation, reduced virulence-factor production and surface-associated motility without measurably inhibiting bacterial growth. QSI-1 enhanced the activity of azithromycin in vitro, and the combination of QSI-1 (25 μM) with azithromycin (0.05 μg/mL) accelerated wound closure and reduced bacterial burden in a murine excisional wound-infection model. QSI-1 showed low cytotoxicity toward mammalian cells at concentrations up to 200 μM. These findings identify QSI-1 and QSI-2 as covalently designed LasB-active antivirulence leads, while direct experimental confirmation of Glu141 covalent modification remains to be established.
- 4 September 2026
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1424, 346228
Discovery of thiol-reactive Staphylococcus aureus sortase A inhibitors from natural products by machine learning and thiocholine mass-shift profiling
- 4 September 2026
- Published by Elsevier in Analytica Chimica Acta
- Vol. 1424, 346228
Discovery of thiol-reactive Staphylococcus aureus sortase A inhibitors from natural products by machine learning and thiocholine mass-shift profiling
- 15 August 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (8) , e71560
Chemical Characterization, Network Pharmacology, Molecular Docking, and Comparative Anti‐Colitic Activity of Polar and Nonpolar Fractions From Raphanus Sativus L. Seeds
The bioactive material basis of Raphanus sativus L. seeds ( Raphani Semen ) against ulcerative colitis (UC) remains unclear. This study compared the chemical profiles and anti‐colitic efficacy of its nonpolar volatile oil (RSO) and polar ethanol extract (RSEE). Chemical profiling using GC‐MS and UPLC‐MS/MS revealed RSO was dominated by phytosterols, whereas RSEE was enriched in phenolic alkaloids, particularly sinapine. In a dextran sulfate sodium (DSS)‐induced murine colitis model, RSEE demonstrated superior efficacy in reducing disease activity and restoring mucosal barriers compared to RSO. Biochemically, RSEE significantly suppressed myeloperoxidase (MPO) and pro‐inflammatory cytokines while enhancing antioxidant defense. Molecular docking confirmed sinapine as a pivotal compound with high binding affinity for MPO and Keap1. Consequently, the polar fraction is identified as the primary active component, with sinapine serving as the key material basis for treating colitis via oxidative stress modulation.
- 15 August 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (8) , e71560
Chemical Characterization, Network Pharmacology, Molecular Docking, and Comparative Anti‐Colitic Activity of Polar and Nonpolar Fractions From Raphanus Sativus L. Seeds
The bioactive material basis of Raphanus sativus L. seeds ( Raphani Semen ) against ulcerative colitis (UC) remains unclear. This study compared the chemical profiles and anti‐colitic efficacy of its nonpolar volatile oil (RSO) and polar ethanol extract (RSEE). Chemical profiling using GC‐MS and UPLC‐MS/MS revealed RSO was dominated by phytosterols, whereas RSEE was enriched in phenolic alkaloids, particularly sinapine. In a dextran sulfate sodium (DSS)‐induced murine colitis model, RSEE demonstrated superior efficacy in reducing disease activity and restoring mucosal barriers compared to RSO. Biochemically, RSEE significantly suppressed myeloperoxidase (MPO) and pro‐inflammatory cytokines while enhancing antioxidant defense. Molecular docking confirmed sinapine as a pivotal compound with high binding affinity for MPO and Keap1. Consequently, the polar fraction is identified as the primary active component, with sinapine serving as the key material basis for treating colitis via oxidative stress modulation.
- Open Access
- 12 August 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (8) , e72034
Raphani Semen Extract Targets the las Quorum Sensing System to Suppress Pseudomonas aeruginosa Biofilm and Signal Molecule Production
Raphanus sativus L. seeds (Raphani Semen, RS) are traditionally used in Chinese medicine for respiratory and gastrointestinal disorders. Pseudomonas aeruginosa ( P . aeruginosa ) biofilm formation and quorum sensing (QS)‐regulated behaviors contribute significantly to its persistence and resistance, highlighting the need for novel QS‐targeting agents. This study aimed to investigate whether RS extract (RSE) and its characteristic constituents sulforaphane (SFA) and sulforaphene (SFE) inhibit P. aeruginosa biofilm and virulence by targeting specific QS pathways. Using sub‐inhibitory concentrations of RSE (≤ 256 μg/mL), SFA and SFE (12.5–100 μM), we evaluated their effects on biofilm formation, bacterial motility, virulence factor production, and signal molecule levels, combined with fluorescent reporter assays, qRT‐PCR, and UPLC‐Q‐Orbitrap‐MS/MS for mechanistic and phytochemical analysis. Results showed that RSE suppressed biofilm formation by 50.93%, impaired motility, and reduced 3‐oxo‐C12‐HSL production. It downregulated key QS genes ( lasR , lasA , lasB , pqsA , and pqsR ) and inhibited lasB / pqsA reporter activity. Phytochemical analysis identified 71 components, and subsequent validation showed that SFA and SFE replicated these effects and exhibited broader QS inhibition across the las , pqs , and rhl systems. SFA (100 μM) demonstrated particularly strong efficacy, suppressing 3‐oxo‐C12‐HSL by 74.29%. Molecular docking indicated that SFA and SFE can bind to LasB, RhlA, and PqsA, albeit with modest affinities. These findings demonstrate that RSE and its active components, SFA and SFE, are potent QS inhibitors that attenuate P. aeruginosa pathogenicity primarily by disrupting the las system, suggesting their potential as natural anti‐biofilm agents that may target multiple components of the QS system.
- 12 August 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (8) , e72034
Open AccessRaphani Semen Extract Targets the las Quorum Sensing System to Suppress Pseudomonas aeruginosa Biofilm and Signal Molecule Production
Raphanus sativus L. seeds (Raphani Semen, RS) are traditionally used in Chinese medicine for respiratory and gastrointestinal disorders. Pseudomonas aeruginosa ( P . aeruginosa ) biofilm formation and quorum sensing (QS)‐regulated behaviors contribute significantly to its persistence and resistance, highlighting the need for novel QS‐targeting agents. This study aimed to investigate whether RS extract (RSE) and its characteristic constituents sulforaphane (SFA) and sulforaphene (SFE) inhibit P. aeruginosa biofilm and virulence by targeting specific QS pathways. Using sub‐inhibitory concentrations of RSE (≤ 256 μg/mL), SFA and SFE (12.5–100 μM), we evaluated their effects on biofilm formation, bacterial motility, virulence factor production, and signal molecule levels, combined with fluorescent reporter assays, qRT‐PCR, and UPLC‐Q‐Orbitrap‐MS/MS for mechanistic and phytochemical analysis. Results showed that RSE suppressed biofilm formation by 50.93%, impaired motility, and reduced 3‐oxo‐C12‐HSL production. It downregulated key QS genes ( lasR , lasA , lasB , pqsA , and pqsR ) and inhibited lasB / pqsA reporter activity. Phytochemical analysis identified 71 components, and subsequent validation showed that SFA and SFE replicated these effects and exhibited broader QS inhibition across the las , pqs , and rhl systems. SFA (100 μM) demonstrated particularly strong efficacy, suppressing 3‐oxo‐C12‐HSL by 74.29%. Molecular docking indicated that SFA and SFE can bind to LasB, RhlA, and PqsA, albeit with modest affinities. These findings demonstrate that RSE and its active components, SFA and SFE, are potent QS inhibitors that attenuate P. aeruginosa pathogenicity primarily by disrupting the las system, suggesting their potential as natural anti‐biofilm agents that may target multiple components of the QS system.
- Open Access
- 3 April 2026
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (10) , 6852-6874
Machine learning-driven discovery of aniline phenylacetate derivatives as LasR-targeted biofilm inhibitors against Pseudomonas aeruginosa infections
- 3 April 2026
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (10) , 6852-6874
Open AccessMachine learning-driven discovery of aniline phenylacetate derivatives as LasR-targeted biofilm inhibitors against Pseudomonas aeruginosa infections
- 13 November 2024
- Published by Wiley in Phytochemical Analysis
- Vol. 36 (3) , 776-792
Dual Assay Validation of Rosmarinus officinalis Extract as an Inhibitor of SARS‐CoV‐2 Spike Protein: Combining Pseudovirus Testing, Yeast Two‐Hybrid, and UPLC‐Q Exactive Orbitrap‐MS Profiling
Introduction: This study evaluates the effectiveness of Traditional Chinese Medicine (TCM) extracts in blocking the interaction between the SARS‐CoV‐2 Spike protein and human ACE2 receptor, utilizing a dual‐method approach to explore the antiviral potential of natural compounds.Objectives: This work aims to evaluate the capability of TCM extracts in inhibiting the SARS‐CoV‐2 Spike protein and ACE2 receptor interaction using advanced biochemical assays.Methods: A dual‐method screening approach was utilized, beginning with a pseudovirus assay to assess the inhibition capabilities of TCM extracts in vitro, followed by a split‐ubiquitin yeast two‐hybrid (Y2H) system to validate interactions in live cells. Active compounds were characterized and quantified using UPLC‐Q‐Exactive‐Orbitrap‐MS.Results: Among the 91 TCM extracts tested, Rosmarinus officinalis exhibited the most potent inhibition in both pseudovirus and Y2H assays, significantly reducing viral entry and disrupting the Spike–ACE2 interaction. Comprehensive chemical profiling via UPLC‐Q‐Exactive‐Orbitrap‐MS identified 132 compounds, including phenolics, flavonoids, and terpenoids.Conclusion: This research validates the use of TCM extracts in viral inhibition strategies, demonstrating the utility of integrating traditional remedies with modern scientific approaches to discover new therapeutic agents.
- 13 November 2024
- Published by Wiley in Phytochemical Analysis
- Vol. 36 (3) , 776-792
Dual Assay Validation of Rosmarinus officinalis Extract as an Inhibitor of SARS‐CoV‐2 Spike Protein: Combining Pseudovirus Testing, Yeast Two‐Hybrid, and UPLC‐Q Exactive Orbitrap‐MS Profiling
Introduction: This study evaluates the effectiveness of Traditional Chinese Medicine (TCM) extracts in blocking the interaction between the SARS‐CoV‐2 Spike protein and human ACE2 receptor, utilizing a dual‐method approach to explore the antiviral potential of natural compounds.Objectives: This work aims to evaluate the capability of TCM extracts in inhibiting the SARS‐CoV‐2 Spike protein and ACE2 receptor interaction using advanced biochemical assays.Methods: A dual‐method screening approach was utilized, beginning with a pseudovirus assay to assess the inhibition capabilities of TCM extracts in vitro, followed by a split‐ubiquitin yeast two‐hybrid (Y2H) system to validate interactions in live cells. Active compounds were characterized and quantified using UPLC‐Q‐Exactive‐Orbitrap‐MS.Results: Among the 91 TCM extracts tested, Rosmarinus officinalis exhibited the most potent inhibition in both pseudovirus and Y2H assays, significantly reducing viral entry and disrupting the Spike–ACE2 interaction. Comprehensive chemical profiling via UPLC‐Q‐Exactive‐Orbitrap‐MS identified 132 compounds, including phenolics, flavonoids, and terpenoids.Conclusion: This research validates the use of TCM extracts in viral inhibition strategies, demonstrating the utility of integrating traditional remedies with modern scientific approaches to discover new therapeutic agents.